A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia
CHEST Journal2016Vol. 151(6), pp. 1239–1246
Citations Over TimeTop 1% of 2016 papers
Marin H. Kollef, Jean-Damien Ricard, Damien Roux, Bruno François, Eleni Ischaki, Zsolt Rozgonyi, Thierry Boulain, Zsolt Iványi, János Gál, Denis Garot, Firas Koura, Epaminondas Zakynthinos, George Dimοpoulos, Antoní Torres, Wayne Danker, A. Bruce Montgomery
Related Papers
- → Amikacin-Fosfomycin at a Five-to-Two Ratio: Characterization of Mutation Rates in Microbial Strains Causing Ventilator-Associated Pneumonia and Interactions with Commonly Used Antibiotics(2014)24 cited
- → Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study*(2019)23 cited
- → An in vitro experimental study of the effect of fosfomycin in combination with amikacin, ciprofloxacin or meropenem on biofilm formation by multidrug-resistant urinary isolates of Escherichia coli(2019)19 cited
- → <p>Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant <em>Staphylococcus aureus</em></p>(2020)9 cited
- → Fosfomycin-resistance Plasmids Determine an Intracellular Modification of Fosfomycin(1985)14 cited